Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razvan L Cornea

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Biomolecular Screening|August 28, 2012
High-throughput FRET assay yields allosteric SERCA activatorsRazvan L Cornea, Simon J Gruber, Elizabeth L Lockamy, et al.
The Journal of Physiology|May 5, 2025
Catecholaminergic polymorphic ventricular tachycardia-linked ryanodine receptor variants exhibit domain-specific calcium leak and calmodulin affinity propertiesHitoshi Uchinoumi, Xiaoqiong Dong, Ivanita Stefanon, et al.
Journal of Molecular and Cellular Cardiology|April 1, 2019
Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814Kafa Walweel, Nieves Gomez-Hurtado, Robyn T Rebbeck, et al.
Circulation Research|February 25, 2014
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutantsHyun Seok Hwang, Florentin R Nitu, Yi Yang, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
<i>ent</i> -Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- miceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Circulation. Arrhythmia and Electrophysiology|August 13, 2016
Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and SparksNieves Gomez-Hurtado, Nicole J Boczek, Dmytro O Kryshtal, et al.
The Journal of Biological Chemistry|November 19, 2025
Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeuticsRoman Nikolaienko, Elisa Bovo, Jonathan C Solberg, et al.
Molecular Pharmacology|January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> MiceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Dynamic-Structure Redesign of Calmodulin Reveals Mechanistic Constraints on Ryr2 RegulationVladimir Bogdanov, Svetlana Tikunova, Nicolas Fadell, et al.
NPJ Parkinson'S Disease|June 29, 2021
Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensorsAnthony R Braun, Elly E Liao, Mian Horvath, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Biomolecular Screening|August 28, 2012
High-throughput FRET assay yields allosteric SERCA activatorsRazvan L Cornea, Simon J Gruber, Elizabeth L Lockamy, et al.
The Journal of Physiology|May 5, 2025
Catecholaminergic polymorphic ventricular tachycardia-linked ryanodine receptor variants exhibit domain-specific calcium leak and calmodulin affinity propertiesHitoshi Uchinoumi, Xiaoqiong Dong, Ivanita Stefanon, et al.
Journal of Molecular and Cellular Cardiology|April 1, 2019
Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814Kafa Walweel, Nieves Gomez-Hurtado, Robyn T Rebbeck, et al.
Circulation Research|February 25, 2014
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutantsHyun Seok Hwang, Florentin R Nitu, Yi Yang, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
<i>ent</i> -Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- miceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Circulation. Arrhythmia and Electrophysiology|August 13, 2016
Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and SparksNieves Gomez-Hurtado, Nicole J Boczek, Dmytro O Kryshtal, et al.
The Journal of Biological Chemistry|November 19, 2025
Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeuticsRoman Nikolaienko, Elisa Bovo, Jonathan C Solberg, et al.
Molecular Pharmacology|January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> MiceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Dynamic-Structure Redesign of Calmodulin Reveals Mechanistic Constraints on Ryr2 RegulationVladimir Bogdanov, Svetlana Tikunova, Nicolas Fadell, et al.
NPJ Parkinson'S Disease|June 29, 2021
Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensorsAnthony R Braun, Elly E Liao, Mian Horvath, et al.
Pageof 7